HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D M Zisterer Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

1/2001Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D M Zisterer Research Topics

Disease

3Neoplasms (Cancer)
01/2016 - 04/2000
2Necrosis
01/2011 - 01/2002
2Breast Neoplasms (Breast Cancer)
03/2001 - 02/2001
1Multiple Myeloma
01/2011
1Glioma (Gliomas)
08/2001
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2001
1Lymphoma (Lymphomas)
04/2000

Drug/Important Bio-Agent (IBA)

2LigandsIBA
01/2011 - 03/2001
2Estrogen ReceptorsIBA
03/2001 - 02/2001
2Estrogen Receptor Modulators (Antiestrogen)IBA
03/2001 - 02/2001
1TubulinIBA
01/2016
1Death Domain ReceptorsIBA
01/2011
14- acetoxy- 5- (1- (naphthyl))naphtho(2,3- b)pyrrolo(2,1- d)(1,4)oxazepineIBA
01/2011
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2011
1CaspasesIBA
01/2002
1SB 203580IBA
08/2001
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2001
1Peptide Hydrolases (Proteases)FDA Link
08/2001
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2001
1NF-kappa B (NF-kB)IBA
08/2001
1Mitogen-Activated Protein KinasesIBA
08/2001
1DNA Repair EnzymesIBA
08/2001
1Estrogen Receptor AntagonistsIBA
03/2001
1TamoxifenFDA LinkGeneric
03/2001
1Biological ProductsIBA
02/2001
1Etoposide (VP 16)FDA LinkGeneric
01/2001
1StaurosporineIBA
01/2001
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2001
1ChromatinIBA
04/2000
1Pharmaceutical PreparationsIBA
04/2000

Therapy/Procedure

1Therapeutics
01/2016